(PDF) CCS/CHFS Heart Failure Guidelines: Clinical Trial

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Canadian Journal of Cardiology - Canada

doi 10.1016/j.cjca.2019.11.036

Full Text

Open PDF

Abstract

Available in full text

Date

February 1, 2020

Authors

Estrellita Estrella-Holder

Publisher

Elsevier BV

Amanote Research

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis

Canadian Journal of Cardiology - Canada

doi 10.1016/j.cjca.2019.11.036

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Surgical Management of Functional Mitral Regurgitation in Heart Failure Patients

Effect of Mitral Regurgitation on Chronic Heart Failure Course and Structure-Functional Heart State

Functional Mitral Regurgitation

Observed Versus Predicted Mortality After MitraClip Treatment in Patients With Symptomatic Heart Failure and Significant Functional Mitral Regurgitation

Effects of Eythropoietin Administration on Mitral Regurgitation and Left Ventricular Remodeling in Heart Failure Patients

Primary Mitral Valve Regurgitation: Update and Review

Myocardial Force-Frequency Defect in Mitral Regurgitation Heart Failure Is Reversed by Forskolin

Chronic Heart Failure: Clinical Guidelines and Real Clinical Practice

Alterations of Myocardial Dynamic Stiffness Implicating Abnormal Crossbridge Function in Human Mitral Regurgitation Heart Failure